Y-mAbs Therapeutics Inc. (YMAB)

YMAB trades at $8.59, 14.5% above the near-term max pain of $7.5 expiring Sep 19, 2025 (10 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$9), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for YMAB shows a downward trend from 9 to 2.5, indicating bearish sentiment or hedging activity. The 96% spread signals divergent expectations across timeframes. Most levels below 8.59 may cap rallies. Strong magnetic level at 8 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.